Streetbeat News

Earnings

MREO

Mereo BioPharma Group reported H1 EPS of $(0.03) and sales of $9.00M, down 82.22% from $50.61M YoY. The company's cash balance of $53.1M is expected to fund operations into 2026.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:37 am

WLY

Wiley has reaffirmed its financial outlook for fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:32 am

WLY

John Wiley & Sons (NYSE:WLY) reported Q1 earnings of $0.27 per share, beating the analyst consensus estimate of $(0.06) by 550 percent. This is a 25 percent decrease from the same period last year. The company also reported quarterly sales of $451.00 million, beating the analyst consensus estimate of $360.90 million by 24.97 percent, but a 7.50 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:32 am

YEXT

Yext Inc's shares are trading lower by around 12% despite reporting mixed Q2 FY24 earnings with a 2% Y/Y revenue growth to $102.6 million, beating the consensus of $101.97 million. The company also reported a 9% Y/Y increase in gross profit to $80.2 million and an adjusted EBITDA of $11.8 million, higher than $0.9 million a year ago. The company raised its FY24 outlook for Adjusted EPS to $0.29-$0.30 and revised revenue guidance to $405 million-$407 million.

Portfolio Pulse from Lekha Gupta

September 07, 2023 | 11:24 am

MEI

MEI has revised its Q2 and FY24 forecasts downwards due to operational inefficiencies and costs related to the discontinuation of Dabir Surfaces and acquisition of Nordic Lights. Q2 net sales are expected to be $285M-$295M, down from $310.52M estimated, and adjusted EPS is expected to be $0.12-$0.17, down from $0.49 estimated. FY24 net sales are expected to be $1.14B-$1.18B, down from $1.15B-$1.20B, and adjusted EPS is expected to be $0.88-$1.08, down from $1.55-$1.75. FY25 forecasts remain unchanged.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:17 am

ABM

ABM Industries has revised its FY23 adjusted EPS guidance range to $3.40-$3.50, down from the previous forecast of $3.40-$3.60. This is also below the consensus estimate of $3.52.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:14 am

AXTA

DGICA

SR

Insiders at Axalta Coating Systems Ltd. (AXTA), Spire Inc. (SR), and Donegal Group Inc. (DGICA) have recently made notable purchases of their companies' stocks. This could indicate their confidence in the companies' prospects or that they view the stocks as bargains. However, Axalta and Spire reported worse-than-expected financial results, while Donegal posted better-than-expected quarterly sales.

Portfolio Pulse from Lisa Levin

September 07, 2023 | 11:13 am

SCWX

SecureWorks has revised its FY24 revenue forecast to $360M-$368M, down from the previous estimate of $380M-$400M and below the consensus of $384.49M. The company also expects a non-GAAP net loss per share of $(0.36)-$(0.41), compared to the consensus of $(0.39) and previous estimate of $(0.34)-$(0.43).

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:12 am

GIII

G-III Apparel anticipates Q3 FY24 sales to be around $1.13B, with an adjusted EPS of $2.03-$2.13, surpassing the consensus estimates of $1.16B and $1.83 respectively.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:12 am

GIII

G-III Apparel has revised its FY24 adjusted earnings guidance to $3.20-$3.30 per share, up from the previous guidance of $2.80-$2.90. The consensus estimate was $2.80. The company also projects an adjusted EBITDA of $284M-$289M.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 11:10 am